ZA201000739B - Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism - Google Patents

Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism

Info

Publication number
ZA201000739B
ZA201000739B ZA201000739A ZA201000739A ZA201000739B ZA 201000739 B ZA201000739 B ZA 201000739B ZA 201000739 A ZA201000739 A ZA 201000739A ZA 201000739 A ZA201000739 A ZA 201000739A ZA 201000739 B ZA201000739 B ZA 201000739B
Authority
ZA
South Africa
Prior art keywords
disease caused
agent
bone metabolism
abnormal bone
therapeutic agent
Prior art date
Application number
ZA201000739A
Other languages
English (en)
Inventor
Eiji Ochiai
Miyuki Nishiga
Kenichiro Takagi
Yoshiaki Azuma
Original Assignee
Teijin Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd
Publication of ZA201000739B publication Critical patent/ZA201000739B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA201000739A 2007-08-02 2010-02-01 Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism ZA201000739B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93526207P 2007-08-02 2007-08-02

Publications (1)

Publication Number Publication Date
ZA201000739B true ZA201000739B (en) 2010-10-27

Family

ID=40304451

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000739A ZA201000739B (en) 2007-08-02 2010-02-01 Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism

Country Status (10)

Country Link
US (1) US20100216747A1 (es)
EP (1) EP2177219A4 (es)
JP (1) JPWO2009017222A1 (es)
KR (1) KR20100045450A (es)
CN (1) CN101808640A (es)
AU (1) AU2008283297A1 (es)
CA (1) CA2694638A1 (es)
MX (1) MX2010001047A (es)
WO (1) WO2009017222A1 (es)
ZA (1) ZA201000739B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100014090A (ko) * 2008-08-01 2010-02-10 동화약품주식회사 벤즈아미딘 유도체 또는 이의 염, 및 비스포스포네이트를 포함하는 골다공증의 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065313T5 (es) * 1993-05-15 2004-01-01 Roche Diagnostics Gmbh Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
KR100454767B1 (ko) * 2001-07-19 2004-11-03 동화약품공업주식회사 4-[(4-티아졸릴)페녹시]알콕시-벤즈아미딘 유도체의골다공증 예방 및 치료제로서의 용도
JP2003292453A (ja) * 2002-04-02 2003-10-15 Asahi Kasei Corp 骨疾患治療用医薬複合剤
JPWO2005002590A1 (ja) * 2003-07-01 2006-08-10 アステラス製薬株式会社 骨量増加誘導剤

Also Published As

Publication number Publication date
CN101808640A (zh) 2010-08-18
MX2010001047A (es) 2010-03-03
JPWO2009017222A1 (ja) 2010-10-21
WO2009017222A1 (ja) 2009-02-05
AU2008283297A1 (en) 2009-02-05
EP2177219A4 (en) 2010-09-29
KR20100045450A (ko) 2010-05-03
CA2694638A1 (en) 2009-02-05
US20100216747A1 (en) 2010-08-26
EP2177219A1 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
IL197001A0 (en) Combination treatment for metabolic disorders
GB0720762D0 (en) Assembly for orthopaedic surgery
GB2455238B (en) Patient monitor
IL195361A0 (en) Preventive or remedy for inflammatory disease
EP2119444A4 (en) THERAPEUTIC AGENT FOR PAIN
ZA200809528B (en) Treatment for depressive disorders
SI2292231T1 (sl) Terapevtsko sredstvo za stenozo spinalnega kanala
HK1136966A1 (zh) 用於皮膚消毒的溫和組合物
IL232619A0 (en) Preparations suitable for the treatment of diseases of the spine and related disorders and conditions
ZA200809527B (en) Treatment for depressive disorders
PL2214683T3 (pl) Dawkowanie jednostkowe dla zdrowia mózgu
EP2119438A4 (en) MEANS FOR REDUCING BONE MATERIAL CHANGE
EP2322220A4 (en) THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR ARTHROSIS
IL219235A0 (en) Bisphosphonate compounds for treating bone metabolism disorders
GB0700645D0 (en) Targets for disease therapy
GB0701456D0 (en) Treatment for respiratory disease
ZA201000739B (en) Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism
EP2305629A4 (en) THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
GB0804968D0 (en) Composition for bone health maintenance
EP2127658A4 (en) THERAPEUTIC AGENT AGAINST MORBUS MENIERE
EP2392338A4 (en) PROPHYLACTIC OR THERAPEUTIC FOR DISEASES RELATED TO ABNORMAL BONE MATERIAL CHANGE
EP2210878A4 (en) THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
GB0700655D0 (en) Targets for disease therapy
GB0700647D0 (en) Targets for disease therapy